MAPT and Alzheimer disease: It has also been shown that SeMet can upregulate AMPK expression and initiate autophagy to clear tau in 3xTg-AD mice by activating the AMPK/mTOR pathway, suggesting that SeMet might be an effective drug candidate for the treatment of Alzheimer’s disease (AD) (43).